ASB16 and prostate adenocarcinoma: In addition, among the 3 cancer types—ACC, p =0.009; LIHC, p =0.019; and PRAD, p =0.016—high ASB16-AS1 expression represented worse PFS; only one cancer type—PAAD, p <0.001) represented better PFS.